Literature DB >> 15490967

Chrysophiles versus chrysophobes: the white asbestos controversy, 1950s-2004.

Geoffrey Tweedale1, Jock McCulloch.   

Abstract

In the first half of the twentieth century, asbestos was a controversial mineral because of its association with asbestosis and asbestos-related lung cancer. It has proved no less so since the 1960s, when another asbestos cancer, mesothelioma, was identified. Mesothelioma appeared to be more strongly linked with blue asbestos (crocidolite) than with the other asbestos varieties, brown (amosite) and white (chrysotile). This finding triggered a fierce debate between "chrysophiles" (those who declared chrysotile innocuous) and "chrysophobes" (those who believed it was a mortal hazard). This essay attempts the first history of the chrysotile controversy, which shows that a scientific consensus on the safety of white asbestos was very slow to emerge. This was only partly due to the complexities of scientific research. Political, economic, and social factors have militated against a speedy resolution of the debate, facilitating the continued production and use of asbestos in the developing world.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15490967     DOI: 10.1086/426196

Source DB:  PubMed          Journal:  Isis        ISSN: 0021-1753            Impact factor:   0.688


  3 in total

Review 1.  Malignant mesothelioma: facts, myths, and hypotheses.

Authors:  Michele Carbone; Bevan H Ly; Ronald F Dodson; Ian Pagano; Paul T Morris; Umran A Dogan; Adi F Gazdar; Harvey I Pass; Haining Yang
Journal:  J Cell Physiol       Date:  2012-01       Impact factor: 6.384

2.  The development of MM is strongly correlated with exposure to asbestos and erionite, as well as to simian virus 40”.

Authors:  Leonardo de Assis; Mauro César Isoldi
Journal:  J Bras Pneumol       Date:  2014-10       Impact factor: 2.624

Review 3.  Clinical and prognostic features of erionite-induced malignant mesothelioma.

Authors:  Ersin Demirer; Christian F Ghattas; Mohamed O Radwan; Elamin M Elamin
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.